![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 19, 15741-15746, May 11, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Bone and Mineral Research Program, The Garvan Institute of
Medical Research, Sydney, New South Wales 2010, Australia
1,25-Dihydroxyvitamin D3
(vitamin D) and transforming growth factor-
Cross-talk between 1,25-Dihydroxyvitamin D3 and
Transforming Growth Factor-
Signaling Requires Binding of VDR and
Smad3 Proteins to Their Cognate DNA Recognition Elements*
,
(TGF-
)
regulate diverse biological processes including cell proliferation and
differentiation through modulation of the expression of target genes.
Members of the Smad family of proteins function as effectors of TGF-
signaling pathways whereas the vitamin D receptor (VDR) confers vitamin
D signaling. We investigated the molecular mechanisms by which
TGF-
and vitamin D signaling pathways interact in the regulation of
the human osteocalcin promoter. Synergistic activation of the
osteocalcin gene promoter by TGF-
and vitamin D was observed in
transient transfection experiments. However, in contrast to a previous
report by Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M.,
Watanabe, M., Kashiwagi, K., Toriyabe, T., Kawabata, M., Miyazono, K.,
and Kato, S. (1999) Science, 283, 1317-1321, synergistic
activation was not detectable when the osteocalcin vitamin D response
element (VDRE) alone was linked to a heterologous promoter. Inclusion
of the Smad binding elements (SBEs) with the VDRE in the heterologous
promoter restored synergistic activation. Furthermore, this synergy was
dependent on the spacing between VDRE and SBEs. The Smad3-Smad4
heterodimer was found to bind in gel shift assay to two distinct DNA
segments of the osteocalcin promoter:
1030 to
989 (SBE3) and
418
to
349 (SBE1). Deletion of SBE1, which is proximal to the VDRE, but
not the distal SBE3 in this promoter reporter abolished TGF-
responsiveness and eliminated synergistic co-activation with vitamin
D. Thus the molecular mechanism, whereby Smad3 and VDR mediate
cross-talk between the TGF-
and vitamin D signaling pathways,
requires both a VDRE and a SBE located in close proximity to the target promoter.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Muscle Development
Unit, Children's Medical Research Institute, Wentworthville NSW 2145, Australia. Tel.: 61-2-9687-2800l; Fax: 61-2-9687-2120; E-mail:
nsubramaniam@cmri.usyd.edu.au.
This article has been cited by other articles:
![]() |
W. Al-Badr and K. J. Martin Vitamin D and Kidney Disease Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1555 - 1560. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Suh, J. Huang, Y.-Y. Park, H.-A Seong, D. Kim, M. Shong, H. Ha, I.-K. Lee, K. Lee, L. Wang, et al. Orphan Nuclear Receptor Small Heterodimer Partner Inhibits Transforming Growth Factor-beta Signaling by Repressing SMAD3 Transactivation J. Biol. Chem., December 22, 2006; 281(51): 39169 - 39178. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul Transforming Growth Factor-{beta}1 to the Bone Endocr. Rev., October 1, 2005; 26(6): 743 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Lyakh, M. Sanford, S. Chekol, H. A. Young, and A. B. Roberts TGF-{beta} and Vitamin D3 Utilize Distinct Pathways to Suppress IL-12 Production and Modulate Rapid Differentiation of Human Monocytes into CD83+ Dendritic Cells J. Immunol., February 15, 2005; 174(4): 2061 - 2070. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Aurrekoetxea-Hernandez and E. Buetti Transforming Growth Factor {beta} Enhances the Glucocorticoid Response of the Mouse Mammary Tumor Virus Promoter through Smad and GA-Binding Proteins J. Virol., March 1, 2004; 78(5): 2201 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Place, N. Suh, C. R. Williams, R. Risingsong, T. Honda, Y. Honda, G. W. Gribble, L. M. Leesnitzer, J. B. Stimmel, T. M. Willson, et al. The Novel Synthetic Triterpenoid, CDDO-Imidazolide, Inhibits Inflammatory Response and Tumor Growth in Vivo Clin. Cancer Res., July 1, 2003; 9(7): 2798 - 2806. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Cao, K. C. Flanders, D. Bertolette, L. A. Lyakh, J. U. Wurthner, W. T. Parks, J. J. Letterio, F. W. Ruscetti, and A. B. Roberts Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells Blood, January 15, 2003; 101(2): 498 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Kang, K.-E. Huang, S. Y. Chang, W.-L. Ma, W.-J. Lin, and C. Chang Differential Modulation of Androgen Receptor-mediated Transactivation by Smad3 and Tumor Suppressor Smad4 J. Biol. Chem., November 8, 2002; 277(46): 43749 - 43756. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Peterziel, K. Unsicker, and K. Krieglstein TGF{beta} induces GDNF responsiveness in neurons by recruitment of GFR{alpha}1 to the plasma membrane J. Cell Biol., October 14, 2002; 159(1): 157 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Shattuck, J. Costa, M. Bernstein, R. T. Jensen, D. C. Chung, and A. Arnold Mutational Analysis of Smad3, a Candidate Tumor Suppressor Implicated in TGF-{beta} and Menin Pathways, in Parathyroid Adenomas and Enteropancreatic Endocrine Tumors J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3911 - 3914. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-G. Chen, H. M. Lui, S.-L. Lin, J. M. Lee, and S.-Y. Ying Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin Experimental Biology and Medicine, February 1, 2002; 227(2): 75 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Leong, N. Subramaniam, J. Figueroa, J. L. Flanagan, M. J. Hayman, J. A. Eisman, and A. P. Kouzmenko Ski-interacting Protein Interacts with Smad Proteins to Augment Transforming Growth Factor-beta -dependent Transcription J. Biol. Chem., May 18, 2001; 276(21): 18243 - 18248. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |